Ying A. Wang
University of Southern California(US)Bayer (United States)(US)Institute for Healthcare Improvement(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Glutathione Transferases and Polymorphisms, Science, Research, and Medicine, Genetic Associations and Epidemiology, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial(2013)586 cited
- → Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction(2010)355 cited
- → Association of Genome-Wide Variation With the Risk of Incident Heart Failure in Adults of European and African Ancestry(2010)197 cited
- → Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer(2015)160 cited
- → Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial(2020)97 cited
- → Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study(2023)96 cited